Skip to main content
European Commission logo
Enterprise Europe Network

UK company seeks packaging manufacturer to produce disposable bedside urinals, bowls, and dishes from post-harvest surplus biomass under a licencing agreement.

Summary

Closed for EoI
Profile Type
  • Technology offer
POD Reference
TOGB20230526013
Term of Validity
26 May 2023 - 25 May 2025
Company's Country
  • United Kingdom
Type of partnership
  • Commercial agreement with technical assistance
Targeted Countries
  • All countries
Contact the EEN partner nearest to you for more information.
Find my local partner

General information

Short Summary
A UK company has designed and patented several products for the medical and healthcare sector including bedside disposable urinals and bowls. Those can be easily disposed off through hospital macerators.

The products are made from cellulosic fibres, recycled, virgin or composites of post-harvest surplus biomass.

They are seeking a manufacturer familiar with this material to manufacture the products to the standard PAA99:1999 BS / ISBN: 0 580 28276 7 under a licence agreement.
Full Description
The company has its origins in the simple idea of using biomass derived materials to substitute plastics.

The waterproof disposable urinals, come in a collapsed near flat state and just need to be opened for use. When the urinals are filled, they are easy to transport to a macerator for maceration and disposal.

One of the biggest challenges for hospitals is storage space, and the disposal of all the single use products and materials used on a day-to-day basis. Traditional paper and cardboard urine bottles do not have the optimum shape and take up a lot of space. This new product supplied in a flat state takes 20 times less space in hospital wards, providing a huge benefit.

Innovative use of cellulosic based containers replaces the use of metal receptacles, which needs chemical cleaning, increase energy costs (heating water for cleaning) and consume staff time (for manually cleaning).

So, a partner is sought to primarily manufacture the products under a licence agreement. However, there are other areas of support that would help the partnership grow: -
- The ability to test the products in a hospital environment to further fine tune the design. Ability to scale up manufacture as required,
- The capability to act as a distributor for the Products.

The product would be manufactured abroad for international sales as the company currently has a UK manufacturer.
Advantages and Innovations
1. The urine bottle comes in a collapsed near flat state and uses 20 times less space without sacrificing functionality.
2. It can be disposed off using existing hospital macerators causing less pollution and environmental impact and no undue changes to effluent in the waste stream. There is potential for use in non-hospital environment.
3. Has the potential to reduce costs for the healthcare sector
Stage of Development
  • Lab tested
Sustainable Development Goals
  • Goal 3: Good Health and Well-being
  • Goal 11: Sustainable Cities and Communities
  • Goal 15: Life on Land
  • Goal 12: Responsible Consumption and Production
  • Goal 13: Climate Action
IPR status
  • IPR granted

Partner Sought

Expected Role of a Partner
The licensing partner is expected to manufacture the products. However, there are other areas of support that would help the partnership grow: -

1. The ability to test the products in a hospital environment to further fine tune the design.
2. Ability to scale up manufacture as required, and
3. The capability to act as a distributor for the products into the healthcare sector
Type and Size of Partner
  • SME 11-49
  • SME <=10
  • Big company
  • SME 50 - 249
Type of partnership
  • Commercial agreement with technical assistance

Dissemination

Technology keywords
  • 10003007 - Waste to Energy /Resource
  • 10003001 - Biotreatment / Compost / Bioconversion
Market keywords
  • 05007001 - Disposable products
Sector Groups Involved
  • Digital
Targeted countries
  • All countries